Eisai’s Leqembi deemed too costly for NHS
Though the UK became the first country in Europe to authorize use of Eisai and Biogen’s early Alzheimer’s disease drug,…
News
Lexicon to face FDA AdComm for Zynquista approval in diabetes and CKD
Leo Pharma’s Timber bet falls flat following Phase III failure
CTI announces partnership for oncology drug development
Touchlight to supply GMP dbDNA for UK Zika vaccine study
Innovent’s Dupert approved in China to treat lung cancer
FDA accepts BMS’ sBLA for Opdivo-Yervoy combo for HCC
Pathalys secures $105m to advance SHPT drug through approval
